An interventional study of AI system in Colonic Polyp, sponsored by Yanqing Li. Status unknown at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2020-07-24.
Sponsored by Yanqing Li · Not applicable, Interventional, and Other
Among 41 studies in Colonic Polyps with a site in China — 7 open to participants now, 8 under way, none of them phase 3. Colonic Polyps · China.
Among the 41 studies in Colonic Polyps with a site in China, this one is the 8th largest by planned enrollment of the 35 interventional ones that give a count, is one of 4 that started in 2020, is one of 32 with no phase, and was the 20th registered.
377 studies on the registry are indexed under Colonic Polyps; 57 are open to participants now.
Browse Colonic Polyps studies →7 of the 41 studies in Colonic Polyps with a site in China are open now. Recruiting first, the newest first:
DONG WU · Sites in China
Zhejiang University · Sites in China
Shandong University · Sites in China
RenJi Hospital · Sites in China
Zhejiang University · Sites in China
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 39 Colonic Polyps studies recruiting now, 23 (59%) set no upper age limit and 4 (10%) stop at 75 or younger; 3 take children under 18; 11 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
41 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 4 started in 2020.
This study's planned enrollment of 1,000 is above the median of 274 across 250 interventional studies indexed under Colonic Polyps.
Median enrollment 352 across the 35 interventional studies, 1,082 across the 6 observational. Of the 22 that completed or were terminated, 1 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 41 have an industry lead sponsor. The 10 most frequent:
Yanqing Li is the lead sponsor of 13 studies on the registry; 3 are open to participants now.
Yanqing Li has 3 studies filed under Colonic Polyps — fewer than ten, so there is no comparison to draw.
2 of the studies in Colonic Polyps with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07252102Zhejiang UniversityEffect of HFNC on Incidence of Hypoxia During Sedated Gastrointestinal Endoscopy in Critical Patients | 2026-12-28 |
| NCT07314554LanZhou UniversityRecurrence After Gastric and Intestinal Polyp Resection | 2027-02-25 |
Among the 41 studies in Colonic Polyps with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The aim of this study was to assess the performance of AI system in polypectomy
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Other: AI system
The real-time assistance of AI system
polypectomy time
the time for detection in polypectomy
Time frame: 12 months
Start is estimated for Jul 2020; primary completion for Jul 2021, 12 months later.
Of 132 non-industry interventional studies with no phase under Colonic Polyps, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 35. This study's planned 12 months is below that.
Counting every sponsor, half of 149 studies reached it within 17 months; a quarter within 9 and three quarters within 35.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Jul 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Yanqing Li